Navigation Links
TOKU-E Announces Safer and Faster Dissolving, Dust-Free Grade Sodium Dodecyl Sulfate (SDS) for Electrophoresis and Manufacturing Applications
Date:5/29/2012

ROTTERDAM, Netherlands, May 29, 2012 /PRNewswire/ --

TOKU-E Company (http://www.toku-e.com) has announced availability of their newly developed, innovative, ultra-safe, faster dissolving dust-free grade (DF) Sodium Dodecyl Sulfate (SDS).

In animal studies, prolonged exposure to SDS dust particles is known to cause eye and skin irritation. SDS may worsen skin problems in individuals with chronic skin hypersensitivity, with some people being affected more than others. Inhalation of SDS dust can cause acute symptoms like wheezing, coughing, chest tightness and shortness of breath, especially when the person has asthma. Not only does TOKU-E's dust-free SDS alleviate this problem, it also dissolves more quickly in water.

Increased safety and reliability, all stem from the physical properties of TOKU-E's dust-free SDS. While the density of typically manufactured SDS ranges from 0.6-0.7 g/cm[3], TOKU-E has been able to pack the powder to a density of 0.9 g/cm[3], ensuring that the number free-floating particulates is minimized. Additionally, when preparing a stock solution, running an SDS-PAGE or preparing a Tris-glycine SDS-Buffer, dust-free grade saves time by speeding up dissolving times. Internal testing shows that by using tightly packed dust-free grade SDS, dissolving times can be reduced by up to 50%.

Company R&D Director Amy Lee says, "About 5 years ago, TOKU-E received a batch of poor quality SDS from one of our suppliers which did not meet our specifications. Our R&D team was assigned to purify it and keep it for our internal R&D usage. The dust particles of SDS were really annoying and one of our scientists, having asthma, was forced to stay away from the project. In order to reduce dust particles, we decided to try out the pellet form of the product. After three years of research, we found that the water quality, control of bacterial contaminations (sources of DNase RNase and Protease) and a few other parameters are the key to make high quality SDS. Two years ago, we decided to scale up this product and offer it to our customers worldwide. After extensive testing by our R&D team in preparations of Tris-glycine SDS-Buffers, we are assured that dust-free SDS not only provides increased safety in the laboratory, but actually leads to more consistent electrophoresis results. We are really excited that we were able innovate and enhance the safety of this widely used product."

After production of dust-free SDS, each batch is stringently tested to ensure it meets our physical specifications with regard to purity, density, solubility, and appearance, and then packed for shipment to end-users. For specific technical data and southern/western blot data, please visit: http://www.toku-e.com/product/Sodium_Dodecyl_Sulfate_(SDS)/.

About TOKU-E

TOKU-E specializes in the manufacturing of ultra-pure antimicrobials and fine chemicals for use in life science research. The broad range of antimicrobials produced are primarily designed for gene selection, cell culture, microbiology, anti-mycoplasma and diagnostic applications. In order to better serve their European customers, TOKU-E Company established last year a European establishment in Rotterdam, the Netherlands.


'/>"/>
SOURCE TOKU-E BV
Copyright©2010 PR Newswire.
All rights reserved

Related biology technology :

1. Sequenom Announces Participation at the Jefferies Global Healthcare Conference
2. Cell Therapeutics Announces Institutional Investor to Purchase $40 Million of Convertible Preferred Stock and Warrants to Purchase Common Stock
3. EPSRC announces first recipients of Fellowships in Manufacturing
4. Ariosa Diagnostics Announces Publication of Study on Influential Factors Affecting Fetal DNA Concentration in Blood of Pregnant Women
5. Cepheid Announces European Release of Xpert CT/NG and Xpert CT, Delivering Rapid Detection and Differentiation of Chlamydia and Gonorrhoeae
6. Rhythm Announces Phase 1b Results for Ghrelin Prokinetic RM-131 for Diabetic Gastroparesis
7. Diversionary Therapy Announces First Sale of ditto™ dental
8. IntelliCell BioSciences Announces Collaborative Agreement with the University of Florida on Stem Cell and Tissue Repair Research
9. Paratek Announces Appointments of Dennis Molnar as Chief Executive Officer and Director and of Dr. Evan Loh as Chief Medical Officer and Chairman of the Board of Directors
10. Cord Blood America Announces First Quarter Financial Results
11. Sigma-Aldrich Corporation Announces New Credit Facility
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:6/27/2016)... 2016  Global demand for enzymes is forecast ... to $7.2 billion.  This market includes enzymes used ... biofuel production, animal feed, and other markets) and ... Food and beverages will remain the largest market ... of products containing enzymes in developing regions.  These ...
(Date:6/27/2016)... Raleigh, NC (PRWEB) , ... June 27, 2016 ... ... a mission to bring innovative medical technologies, services and solutions to the healthcare ... development and implementation of various distribution, manufacturing, sales and marketing strategies that are ...
(Date:6/24/2016)... Epic Sciences unveiled a liquid biopsy ... PARP inhibitors by targeting homologous recombination deficiency (HRD) ... test has already been incorporated into numerous clinical ... Over 230 clinical trials are investigating ... PARP, ATM, ATR, DNA-PK and WEE-1. Drugs targeting ...
(Date:6/23/2016)... 2016   Boston Biomedical , an industry ... to target cancer stemness pathways, announced that its ... Drug Designation from the U.S. Food and Drug ... including gastroesophageal junction (GEJ) cancer. Napabucasin is an ... cancer stemness pathways by targeting STAT3, and is ...
Breaking Biology Technology:
(Date:5/16/2016)... 2016   EyeLock LLC , a market leader ... of an IoT Center of Excellence in ... development of embedded iris biometric applications. EyeLock,s ... and security with unmatched biometric accuracy, making it the ... DNA. EyeLock,s platform uses video technology to deliver a ...
(Date:4/28/2016)... , April 28, 2016 First quarter 2016: ... up 966% compared with the first quarter of 2015 ... SEK 589.1 M (loss: 18.8) and the operating margin was 40% ... 0.32) Cash flow from operations was SEK 249.9 M ... revenue guidance is unchanged, SEK 7,000-8,500 M. The operating ...
(Date:4/15/2016)... 15, 2016 Research and ... Biometrics Market 2016-2020,"  report to their offering.  , ... , ,The global gait biometrics market is expected ... the period 2016-2020. Gait analysis generates ... be used to compute factors that are not ...
Breaking Biology News(10 mins):